What's in a name: 'significant' results?

Catalin Tufanaru^{1

2

3}

Affiliations

Editorial

Catalin Tufanaru. JBI Database System Rev Implement Rep. 2016.

. 2016 Jan 15;13(12):1-3.

doi: 10.11124/jbisrir-2015-2759.

Catalin Tufanaru^{1

2

3}

No abstract available

Similar articles

What's in a name? Systemic exertion intolerance disease.
[No authors listed] [No authors listed] Lancet. 2015 Feb 21;385(9969):663. doi: 10.1016/S0140-6736(15)60270-7. Epub 2015 Feb 20. Lancet. 2015. PMID: 25706201 No abstract available.
Commentary: the epidemic of obesity--what's in a name?
Flegal KM. Flegal KM. Int J Epidemiol. 2006 Feb;35(1):72-4; discussion 81-2. doi: 10.1093/ije/dyi260. Epub 2005 Dec 8. Int J Epidemiol. 2006. PMID: 16339593 No abstract available.
What's Lost in What's Missing: A Thoughtful Approach to Missing Data in the National Cancer Database.
Boffa DJ. Boffa DJ. Ann Surg Oncol. 2019 Mar;26(3):709-710. doi: 10.1245/s10434-018-07130-9. Epub 2019 Jan 2. Ann Surg Oncol. 2019. PMID: 30603815 No abstract available.
Review of null hypothesis significance testing in the ophthalmic literature: are most 'significant' P values false positives?
Sanfilippo PG, Casson RJ, Yazar S, Mackey DA, Hewitt AW. Sanfilippo PG, et al. Clin Exp Ophthalmol. 2016 Jan-Feb;44(1):52-61. doi: 10.1111/ceo.12570. Epub 2015 Jul 27. Clin Exp Ophthalmol. 2016. PMID: 26140666 Review.
Five easy pieces on evidence-based medicine (4).
Kalso E, Edwards J, McQuay HJ, Moore RA. Kalso E, et al. Eur J Pain. 2002;6(1):89-93. doi: 10.1053/eujp.2001.0306. Eur J Pain. 2002. PMID: 11888232 Review. No abstract available.